Back

Trimetazidine reduces stroke risk in ischemic atrial fibrillation: a territory-wide, propensity-matched study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Antithrombotic and anticoagulant therapy in special populations Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Yuen Ting Cheng

Hong Kong (Hong Kong)

8 More presentations in this session

Presentation thumbnail
Direct oral anticoagulants exhibit lower risks of mortality and bleeding compared to vitamin-k antagonists in atrial fibrillation patients on chronic hemodialysis: a meta-analysis
Doctor H. Jain (Jodhpur, IN)
Abstract Slides Video
Presentation thumbnail
Medication adherence and antithrombotic therapy outcomes: insights from a post-hoc analysis of the AFIRE trial
Doctor N. Chiba (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
Impact of differences in body mass index, body surface area and lean body mass on clinical outcomes in patients with atrial fibrillation receiving edoxaban: 4-year follow-up data from ETNA-AF-Europe
Professor G. Boriani (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Haemorrhagic risk in elderly patients with atrial fibrillation that develop low platelet count during direct oral anticoagulant treatment: insights from the ATHERO-AF study.
Doctor D. Menichelli (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Silent cerebral microvascular disease and longitudinal risk of cognitive decline in atrial fibrillation
Associate Professor Y. Kondo (Chiba, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Antithrombotic and anticoagulant therapy in special populations

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The effect of metformin use on the risk of atrial fibrillation in patients with type 2 diabetes: data from the UK biobank
thumbnail
Congress Presentation
The long-term usage of statin prevents adverse events in patients with atrial fibrillation
thumbnail
Congress Presentation
Risk of atrial fibrillation recurrence after new-onset transient episode during ST-elevation myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources